CO6382162A2 - Composicion inmunogenica multicomponente para la prevencion de enfermedad estreptococica beta hemolica (bhs) - Google Patents
Composicion inmunogenica multicomponente para la prevencion de enfermedad estreptococica beta hemolica (bhs)Info
- Publication number
- CO6382162A2 CO6382162A2 CO11058588A CO11058588A CO6382162A2 CO 6382162 A2 CO6382162 A2 CO 6382162A2 CO 11058588 A CO11058588 A CO 11058588A CO 11058588 A CO11058588 A CO 11058588A CO 6382162 A2 CO6382162 A2 CO 6382162A2
- Authority
- CO
- Colombia
- Prior art keywords
- streptococic
- hemolic
- bhs
- beta
- disease
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 241000193996 Streptococcus pyogenes Species 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
Abstract
Se describen varios polinucleótidos y polipéptidos de estreptococos ß-hemolíticos, particularmente polipéptidos y polinucleótidos de Streptococcus pyogenes. Dos o más de los polipéptidos de la invención pueden formularse para su uso como composiciones inmunogénicas. También se desvelan procedimientos para inmunizar frente a y reducir la infección causada por estreptococos ß-hemolíticos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11148508P | 2008-11-05 | 2008-11-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6382162A2 true CO6382162A2 (es) | 2012-02-15 |
Family
ID=41571714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11058588A CO6382162A2 (es) | 2008-11-05 | 2011-05-12 | Composicion inmunogenica multicomponente para la prevencion de enfermedad estreptococica beta hemolica (bhs) |
Country Status (21)
Country | Link |
---|---|
US (2) | US8563001B2 (es) |
EP (1) | EP2356135B1 (es) |
JP (1) | JP2012508174A (es) |
KR (1) | KR20110081282A (es) |
CN (2) | CN107050442B (es) |
AR (1) | AR074273A1 (es) |
AU (1) | AU2009313615B2 (es) |
BR (1) | BRPI0921286B8 (es) |
CA (1) | CA2741691C (es) |
CO (1) | CO6382162A2 (es) |
DK (1) | DK2356135T3 (es) |
ES (1) | ES2648231T3 (es) |
IL (1) | IL212491A0 (es) |
MX (1) | MX2011004755A (es) |
NO (1) | NO2356135T3 (es) |
NZ (2) | NZ592368A (es) |
PE (1) | PE20120116A1 (es) |
RU (1) | RU2478396C2 (es) |
TW (1) | TW201022442A (es) |
WO (1) | WO2010053986A1 (es) |
ZA (1) | ZA201102894B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2356135T3 (en) * | 2008-11-05 | 2017-12-04 | Wyeth Llc | IMMUNOGEN MULTICOMPONENT COMPOSITION FOR THE PREVENTION OF BETA-HAEMOLYTIC STRUCTURAL TOC (BHS) DISEASE |
EP3034516A1 (en) | 2014-12-19 | 2016-06-22 | Novartis AG | Purification of streptococcal capsular polysaccharide |
TWI598360B (zh) * | 2016-12-19 | 2017-09-11 | 義守大學 | Fsbm重組蛋白及其用途 |
RU2708558C1 (ru) * | 2018-12-13 | 2019-12-09 | Российская Федерация, от имени которой выступает ФОНД ПЕРСПЕКТИВНЫХ ИССЛЕДОВАНИЙ | Способ создания противоопухолевой иммунологической защиты к клеткам лимфомы EL-4 |
Family Cites Families (112)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4152411A (en) | 1977-07-27 | 1979-05-01 | Akzona Incorporated | High specific activity labeled substances |
NZ191327A (en) | 1978-08-24 | 1981-07-13 | W B Martin | Pasteurellosis vaccine comprising antigenic material derived from the a1 and a2 serotypes of pasteurella haemolytica |
US5077044A (en) | 1980-05-19 | 1991-12-31 | The Board Of Trustees Of The Leland Stanford Jr. University | Novel non-reverting shigella live vaccines |
US4837151A (en) | 1980-05-19 | 1989-06-06 | The Board Of Trustees Of The Leland Stanford Junior University, Stanford University | Live vaccines comprising two mutations and foreign antigen |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US5097020A (en) | 1983-07-05 | 1992-03-17 | The University Of Rochester | Immunogenic conjugates |
US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
US4902506A (en) | 1983-07-05 | 1990-02-20 | The University Of Rochester | Immunogenic conjugates |
US5360897A (en) | 1981-08-31 | 1994-11-01 | The University Of Rochester | Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad |
US4454121A (en) | 1982-07-27 | 1984-06-12 | The University Of Tennessee Research Corporation | Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4650764A (en) | 1983-04-12 | 1987-03-17 | Wisconsin Alumni Research Foundation | Helper cell |
US4784948A (en) | 1983-08-10 | 1988-11-15 | The Rockefeller University | Production of streptococcal m protein immunogens and molecular probes |
US4695562A (en) | 1984-04-06 | 1987-09-22 | Univ. Of Tennessee Research Corp. | Synthetic peptide compounds |
JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
GB8424757D0 (en) | 1984-10-01 | 1984-11-07 | Pasteur Institut | Retroviral vector |
US4720489A (en) | 1984-10-15 | 1988-01-19 | Douglas Shander | Hair growth modification with ornithine decarboxylase inhibitors |
FR2573436B1 (fr) | 1984-11-20 | 1989-02-17 | Pasteur Institut | Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins |
JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
US4666829A (en) | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
US5078996A (en) | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
US4772584A (en) | 1986-05-23 | 1988-09-20 | Cleary Paul P | Inhibitor of C5a-mediated chemotaxis |
IT1216262B (it) | 1986-09-02 | 1990-02-22 | Bargellini Andrea | Assorbente,ed utensile cosi'procedimento ed attrezzatura per la realizzato. formazione di un utensile di pulizia a strisce di materiale |
EP0272929B1 (en) | 1986-12-24 | 1996-03-20 | Genentech, Inc. | Enkephalinase for therapeutic use |
US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
US5124153A (en) | 1987-08-24 | 1992-06-23 | University Of Tennessee Research Corp. | Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
US5162226A (en) | 1987-08-24 | 1992-11-10 | University Of Tennessee Research Corp. (U.T.R.C.) | Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
AU3069189A (en) | 1988-02-05 | 1989-08-25 | Trustees Of Columbia University In The City Of New York, The | Retroviral packaging cell lines and processes of using same |
EP0365646B1 (en) | 1988-03-25 | 1996-05-08 | The Rockefeller University | Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
WO1990002806A1 (en) | 1988-09-01 | 1990-03-22 | Whitehead Institute For Biomedical Research | Recombinant retroviruses with amphotropic and ecotropic host ranges |
JP2871709B2 (ja) | 1988-11-21 | 1999-03-17 | 住友製薬株式会社 | 免疫グロブリンg結合活性を有する新規な蛋白質プロテインh、該蛋白質をコードする遺伝子及び該蛋白質の製造法 |
US5354844A (en) | 1989-03-16 | 1994-10-11 | Boehringer Ingelheim International Gmbh | Protein-polycation conjugates |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
CA2039921A1 (en) | 1990-04-16 | 1991-10-17 | Xandra O. Breakefield | Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication |
US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
AU7906691A (en) | 1990-05-23 | 1991-12-10 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Adeno-associated virus (aav)-based eucaryotic vectors |
SE9002212D0 (sv) | 1990-06-21 | 1990-06-21 | Hightech Receptor Ab | Igg binding protein |
DK0542869T3 (da) | 1990-07-31 | 1996-02-05 | Genentech Inc | Vævsplasminogenaktivatorvarianter med nedsat udskillelse |
JP3895366B2 (ja) | 1990-09-25 | 2007-03-22 | キャンタブ ファーマシューティカルズ リサーチ リミティド | ウィルス ワクチン |
US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
IL101715A (en) | 1991-05-02 | 2005-06-19 | Amgen Inc | Recombinant dna-derived cholera toxin subunit analogs |
US6100380A (en) | 1991-10-28 | 2000-08-08 | Cytran, Inc. | Immunomodulating peptides and methods of use |
US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
WO1993014198A1 (en) | 1992-01-08 | 1993-07-22 | The Rockefeller University | Multifunctional surface protein of streptococci |
ATE228565T1 (de) | 1992-03-09 | 2002-12-15 | Univ California | Nukleinsäure, expressionsvektor und zusammensetzungen zur identifizierung und herstellung von rekombinanten sialyltransferasen |
WO1993021220A1 (en) | 1992-04-08 | 1993-10-28 | The Council Of The Queensland Institute Of Medical Research | Synthetic peptides useful in a vaccine against and in the diagnosis of streptococcal infection |
IL107025A0 (en) | 1992-09-16 | 1993-12-28 | Univ Tennessee Res Corp | Recombinant multivalent m protein vaccine |
IL107026A0 (en) | 1992-09-16 | 1993-12-28 | Univ Tennessee Res Corp | Antigen of hybrid m protein and carrier for group a streptococcal vaccine |
WO1994012649A2 (en) | 1992-12-03 | 1994-06-09 | Genzyme Corporation | Gene therapy for cystic fibrosis |
US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
WO1994021807A2 (en) | 1993-03-19 | 1994-09-29 | Cantab Pharmaceuticals Research Limited | Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
FR2705361B1 (fr) | 1993-05-18 | 1995-08-04 | Centre Nat Rech Scient | Vecteurs viraux et utilisation en thérapie génique. |
FR2705686B1 (fr) | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
EP0667912B1 (fr) | 1993-07-13 | 2008-07-02 | Centelion | Vecteurs adenoviraux defectifs et utilisation en therapie genique |
WO1995007358A1 (en) | 1993-07-30 | 1995-03-16 | University Of Medicine & Dentistry Of New Jersey | Efficient gene transfer into primary lymphocytes |
FR2714830B1 (fr) | 1994-01-10 | 1996-03-22 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
FR2715847B1 (fr) | 1994-02-08 | 1996-04-12 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
FR2716459B1 (fr) | 1994-02-22 | 1996-05-10 | Univ Paris Curie | Système hôte-vecteur utilisable en thérapie génique. |
WO1995026411A2 (en) | 1994-03-25 | 1995-10-05 | The Uab Research Foundation | Composition and methods for creating syngeneic recombinant virus-producing cells |
CA2187818A1 (en) | 1994-04-15 | 1995-10-26 | Robert W. Overell | Gene delivery fusion proteins |
US5571515A (en) | 1994-04-18 | 1996-11-05 | The Wistar Institute Of Anatomy & Biology | Compositions and methods for use of IL-12 as an adjuvant |
US5866135A (en) * | 1994-04-21 | 1999-02-02 | North American Vaccine, Inc. | Group A streptococcal polysaccharide immunogenic compositions and methods |
US5505947A (en) | 1994-05-27 | 1996-04-09 | The University Of North Carolina At Chapel Hill | Attenuating mutations in Venezuelan Equine Encephalitis virus |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US5679654A (en) | 1994-09-02 | 1997-10-21 | Brigham & Women's Hospital, Inc. | Capsular polysaccharide immunomodulator |
US5837533A (en) | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
FR2727679B1 (fr) | 1994-12-05 | 1997-01-03 | Rhone Poulenc Rorer Sa | Nouveaux agents de transfection et leurs applications pharmaceutiques |
IL116816A (en) | 1995-01-20 | 2003-05-29 | Rhone Poulenc Rorer Sa | Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof |
FR2730637B1 (fr) | 1995-02-17 | 1997-03-28 | Rhone Poulenc Rorer Sa | Composition pharmaceutique contenant des acides nucleiques, et ses utilisations |
US7153510B1 (en) | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
WO1996039036A1 (en) | 1995-06-05 | 1996-12-12 | The University Of Alabama At Birmingham Research Foundation | Composition and methods for creating syngeneic recombinant virus-producing cells |
FR2741358B1 (fr) | 1995-11-17 | 1998-01-02 | Centre Nat Rech Scient | Production de vecteurs retroviraux par l'intermediaire de vecteurs viraux a base de virus a adn |
US5846547A (en) | 1996-01-22 | 1998-12-08 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
US6355255B1 (en) * | 1998-12-07 | 2002-03-12 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
US5829302A (en) | 1996-05-31 | 1998-11-03 | The National Machinery Company | Cassette tooling |
IT1289387B1 (it) | 1996-07-16 | 1998-10-02 | Zanussi Elettromecc | Perfezionamenti ai circuiti refrigeranti a compressione per apparecchi domestici e simili |
KR20000048628A (ko) | 1996-09-27 | 2000-07-25 | 윌리암 에이취 캘넌, 에곤 이 버그 | 모노네가비랄레스 목의 바이러스에서 감쇠를 책임지는 3' 게놈프로모터 영역 및 폴리머라제 유전자 돌연변이 |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
BR9810500A (pt) | 1997-06-30 | 2000-09-05 | Rhone Poulenc Rorer Sa | Sistema e aparelho para a transferência de ácido nucléico in vivo para o interior de células de organismos eucarióticos pluricelulares |
WO1999001158A1 (fr) | 1997-06-30 | 1999-01-14 | Rhone-Poulenc Rorer S.A. | Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede |
BR9810372A (pt) | 1997-06-30 | 2000-09-05 | Rhone Poulenc Rorer Sa | Processo de transferência de ácido nucléico para o interior de células de organismos eucarióticos pluricelulares in vivo, composição, ácido nucléico e campo elétrico, e, produto de combinação |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
EP1117435B1 (en) | 1998-09-30 | 2007-11-14 | Wyeth Holdings Corporation | Mutant cholera holotoxin as an adjuvant |
US6168911B1 (en) | 1998-12-18 | 2001-01-02 | Eastman Kodak Company | Formulations for preparing metal oxide-based pigment-binder transparent electrically conductive layers |
CA2353802C (en) | 1998-12-22 | 2013-10-01 | The University Of Tennessee Research Corporation | New protective antigen of group a streptococci |
EP1075841A1 (en) | 1999-08-13 | 2001-02-14 | Erasmus Universiteit Rotterdam | Pneumococcal vaccines |
US7256265B2 (en) | 1999-12-03 | 2007-08-14 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
MX357775B (es) * | 2000-10-27 | 2018-07-20 | J Craig Venter Inst Inc | Acidos nucleicos y proteinas de los grupos a y b de estreptococos. |
WO2002077183A2 (en) | 2001-03-21 | 2002-10-03 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
KR100923598B1 (ko) * | 2001-04-13 | 2009-10-23 | 와이어쓰 | 스트렙토코커스 피오게네스의 표면 단백질 |
EP2287311A1 (en) * | 2003-03-04 | 2011-02-23 | Intercell AG | Streptococcus pyogenes antigens |
CN100579985C (zh) * | 2003-05-07 | 2010-01-13 | 英特塞尔股份公司 | 无乳链球菌抗原ⅰ和ⅱ |
EP1648500B1 (en) * | 2003-07-31 | 2014-07-09 | Novartis Vaccines and Diagnostics, Inc. | Immunogenic compositions for streptococcus pyogenes |
RU2263143C2 (ru) * | 2004-01-05 | 2005-10-27 | ГНУ Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева | Штамм бактерий streptococcus pyogenes №289, используемый для изготовления вакцин против стрептококкоза пушных зверей |
WO2005076010A2 (en) | 2004-02-06 | 2005-08-18 | Council Of Scientific And Industrial Research | Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential |
MX2007000016A (es) * | 2004-07-01 | 2007-03-27 | Daiichi Seiyaku Co | Derivados de pirazol. |
EP1778720B1 (en) * | 2004-08-18 | 2010-09-01 | Novabiotics Limited | Antimicrobial peptides comprising an arginine- and/or lysine-containing motif |
EP1807446A2 (en) * | 2004-10-08 | 2007-07-18 | Novartis Vaccines and Diagnostics, Inc. | Immunogenic and therapeutic compositions for streptococcus pyogenes |
CA2593165A1 (en) | 2005-01-05 | 2006-07-13 | Regents Of The University Of Minnesota | Analgesic conjugates |
US7531541B2 (en) | 2005-09-20 | 2009-05-12 | Vanderbilt University | Partial mGluR5 antagonists for treatment of anxiety and CNS disorders |
EP2650014A2 (en) * | 2008-06-20 | 2013-10-16 | Wyeth LLC | Compositions and methods of use of ORF1358 from beta-hemolytic streptococcal strains |
AU2009259951A1 (en) * | 2008-06-20 | 2009-12-23 | Wyeth Llc | Compositions and methods of use of ORF 554 from beta hemolytic Streptococcal strains |
DK2356135T3 (en) * | 2008-11-05 | 2017-12-04 | Wyeth Llc | IMMUNOGEN MULTICOMPONENT COMPOSITION FOR THE PREVENTION OF BETA-HAEMOLYTIC STRUCTURAL TOC (BHS) DISEASE |
-
2009
- 2009-11-04 DK DK09752598.4T patent/DK2356135T3/en active
- 2009-11-04 CN CN201710173133.2A patent/CN107050442B/zh active Active
- 2009-11-04 CA CA2741691A patent/CA2741691C/en active Active
- 2009-11-04 EP EP09752598.4A patent/EP2356135B1/en active Active
- 2009-11-04 ES ES09752598.4T patent/ES2648231T3/es active Active
- 2009-11-04 BR BRPI0921286A patent/BRPI0921286B8/pt active IP Right Grant
- 2009-11-04 CN CN2009801442497A patent/CN102203122A/zh active Pending
- 2009-11-04 NO NO09752598A patent/NO2356135T3/no unknown
- 2009-11-04 NZ NZ59236809A patent/NZ592368A/xx unknown
- 2009-11-04 AR ARP090104260 patent/AR074273A1/es not_active Application Discontinuation
- 2009-11-04 PE PE2011000977A patent/PE20120116A1/es not_active Application Discontinuation
- 2009-11-04 MX MX2011004755A patent/MX2011004755A/es not_active Application Discontinuation
- 2009-11-04 RU RU2011116286/10A patent/RU2478396C2/ru active
- 2009-11-04 WO PCT/US2009/063268 patent/WO2010053986A1/en active Application Filing
- 2009-11-04 KR KR20117010285A patent/KR20110081282A/ko not_active Application Discontinuation
- 2009-11-04 NZ NZ61406409A patent/NZ614064A/en unknown
- 2009-11-04 AU AU2009313615A patent/AU2009313615B2/en active Active
- 2009-11-04 US US12/612,399 patent/US8563001B2/en active Active
- 2009-11-04 JP JP2011534902A patent/JP2012508174A/ja active Pending
- 2009-11-05 TW TW98137615A patent/TW201022442A/zh unknown
-
2011
- 2011-04-18 ZA ZA2011/02894A patent/ZA201102894B/en unknown
- 2011-04-26 IL IL212491A patent/IL212491A0/en unknown
- 2011-05-12 CO CO11058588A patent/CO6382162A2/es not_active Application Discontinuation
-
2013
- 2013-07-16 US US13/943,484 patent/US9127050B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20100119534A1 (en) | 2010-05-13 |
KR20110081282A (ko) | 2011-07-13 |
US20140037669A1 (en) | 2014-02-06 |
DK2356135T3 (en) | 2017-12-04 |
BRPI0921286B1 (pt) | 2021-11-23 |
AU2009313615B2 (en) | 2012-11-29 |
RU2478396C2 (ru) | 2013-04-10 |
BRPI0921286A2 (pt) | 2015-03-24 |
CN107050442A (zh) | 2017-08-18 |
CA2741691A1 (en) | 2010-05-14 |
EP2356135B1 (en) | 2017-10-25 |
US8563001B2 (en) | 2013-10-22 |
AR074273A1 (es) | 2011-01-05 |
ES2648231T3 (es) | 2017-12-29 |
AU2009313615A1 (en) | 2010-05-14 |
EP2356135A1 (en) | 2011-08-17 |
US9127050B2 (en) | 2015-09-08 |
CN107050442B (zh) | 2022-09-13 |
TW201022442A (en) | 2010-06-16 |
NZ614064A (en) | 2015-04-24 |
IL212491A0 (en) | 2011-06-30 |
CN102203122A (zh) | 2011-09-28 |
WO2010053986A1 (en) | 2010-05-14 |
MX2011004755A (es) | 2011-10-10 |
ZA201102894B (en) | 2012-06-27 |
PE20120116A1 (es) | 2012-02-18 |
NO2356135T3 (es) | 2018-03-24 |
JP2012508174A (ja) | 2012-04-05 |
BRPI0921286A8 (pt) | 2018-01-02 |
BRPI0921286B8 (pt) | 2022-10-25 |
NZ592368A (en) | 2013-11-29 |
CA2741691C (en) | 2019-11-26 |
RU2011116286A (ru) | 2012-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012016129A2 (pt) | composto, composição, e, métodos para inibir a atividade de c-met, e para tratar câncer | |
BRPI0908926A2 (pt) | Compostos de policarbonato-poliorganosiloxano e/ou poliuretano-poliorganosiloxano | |
CL2014003171A1 (es) | Composicion liofilizada que comprende al menos una benzodiazepina de formula (i), al menos un excipiente higroscopico seleccionado de disacaridos y dextrano; metodo de preparacion de la composicion farmaceutica. | |
BRPI0922220B8 (pt) | uso de compostos antibacterianos, composição farmacêutica e combinação compreendendo os mesmos | |
NI200800294A (es) | Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmacéuticas que la contienen. | |
BRPI0607455A2 (pt) | composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica | |
CO6480948A2 (es) | Composición farmacéutica para la anticoncepción de emergencia | |
NO20084278L (no) | Bezothiazol derivatives as beta2 adrenoreceptor agonists | |
BR112016002233A2 (pt) | composições de adoçante | |
BR112015022095A8 (pt) | composição farmacêutica, método de fabricação, composição eutética e uso de composições contendo hcl ciclobenzabrina e manitol | |
BR112012011328A2 (pt) | inibidores de akt | |
BRPI0709282B8 (pt) | vacina contra estreptococos | |
CL2007001838A1 (es) | Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih. | |
EA201101116A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
MX2011007456A (es) | Antigenos del dominio de proteina de superficie de union a colageno tipo b (can_b) en vacunas contra bacteria gram positiva. | |
CL2008001048A1 (es) | Compuestos derivados de heterociclos nitrogenados; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto como antibacterianos. | |
EA201101118A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
ECSP088740A (es) | Derivados de tetrahidronaftalina, procedimientos para prepararlos y su uso como antiinflamatorios | |
CL2007002862A1 (es) | Uso del factor de crecimiento epidermico (egf) para tratar neuropatia sensitivo-motora, dolorosa y manifestaciones de neuritis isquemicas; composicion farmaceutica que comprende egf; y uso de la composicion antes dicha. | |
CO6382162A2 (es) | Composicion inmunogenica multicomponente para la prevencion de enfermedad estreptococica beta hemolica (bhs) | |
TN2015000542A1 (en) | Novel compounds for the treatment of cancer | |
CL2007002812A1 (es) | Compuestos derivados de quinolina; composicion farmaceutica, utiles para inhibir el vih. | |
EA200970831A1 (ru) | Композиции, содержащие конъюгаты пэг-интерферон-альфа и рафинозу в качестве криопротектора | |
MX2009008249A (es) | Composicion farmaceutica que comprende derivado de camptotecina. | |
UY29481A1 (es) | Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como antiinflamatorios. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |